Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of genetic disorders and cancer
3.2.1.2 Technological advancements in molecular cytogenetics
3.2.1.3 Rising adoption of personalized medicine
3.2.1.4 Expanding applications in research and clinical diagnostics
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High cost of molecular cytogenetic tests
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Reagents and kits
5.3.1 Testing kits
5.3.2 Probes
5.3.3 Fluorescent affinity reagents
5.3.4 Other reagents and kits
5.4 Consumables
5.5 Software & services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Comparative genomic hybridization (CGH)
6.2.1 Array-based comparative genomic hybridization (aCGH)
6.2.2 Standard comparative genomic hybridization (sCGH)
6.3 Fluorescence in-situ hybridization (FISH)
6.4 Immunohistochemistry
6.5 Karyotyping
6.5.1 Spectral
6.5.2 Virtual
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Genetic disorders
7.3 Oncology
7.4 Personalized medicine
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Clinical & research laboratories
8.3 Academic research institutes
8.4 Pharmaceutical & biotech companies
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Agilent Technologies, Inc.
10.3 Bio-Rad Laboratories, Inc.
10.4 BioView Ltd.
10.5 Danaher Corporation
10.6 F. Hoffmann-La Roche Ltd.
10.7 Illumina, Inc.
10.8 MetaSystems
10.9 PerkinElmer, Inc.
10.10 Sysmex Corporation
